Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 30 entries
Sorted by: Best Match Show Resources per page
[Present state of chemotherapy of cancer].

Clinica nuova; rassegna del progresso medico internazionale

[No authors listed]
PMID: 13116424
Clin Nuova Rass Prog Med Int. 1953 Apr 18-25;16(16):551-7.

No abstract available.

Cite
STATO attuale della chemioterapia del cancro. [Present state of chemotherapy of cancer]. Clin Nuova Rass Prog Med Int. 1953;16(16):551-7
(1953). STATO attuale della chemioterapia del cancro. [Present state of chemotherapy of cancer]. Clinica nuova; rassegna del progresso medico internazionale, 16(16), 551-7.
"STATO attuale della chemioterapia del cancro." [Present state of chemotherapy of cancer]. Clinica nuova; rassegna del progresso medico internazionale vol. 16,16 (1953): 551-7.
STATO attuale della chemioterapia del cancro. [Present state of chemotherapy of cancer]. Clin Nuova Rass Prog Med Int. 1953 Apr 18-25;16(16):551-7. Undetermined. PMID: 13116424.
Copy Download .nbib Format: NLM
Anti-cancer chemotherapy.

Minerva medica

CAVANNA D.
PMID: 20263622
Minerva Med. 1947 Aug 04;38(31):98-100.

No abstract available.

Cite
CAVANNA D. Chemioterapia anticancerigeno. Anti-cancer chemotherapy. Minerva Med. 1947;38(31):98-100
CAVANNA, D. (1947). Chemioterapia anticancerigeno. Anti-cancer chemotherapy. Minerva medica, 38(31), 98-100.
CAVANNA, D. "Chemioterapia anticancerigeno." Anti-cancer chemotherapy. Minerva medica vol. 38,31 (1947): 98-100.
CAVANNA D. Chemioterapia anticancerigeno. Anti-cancer chemotherapy. Minerva Med. 1947 Aug 04;38(31):98-100. Italian. PMID: 20263622.
Copy Download .nbib Format: NLM
Growth-inhibition of ht29 cells exposed to N-methylformamide correlates with altered expression of alpha-6/beta-4 integrin.

International journal of oncology

Delbufalo D, Zupi G, Dagnano I, Falcioni R, Marangolo M, Sacchi A.
PMID: 21584516
Int J Oncol. 1992 Jun;1(1):97-105. doi: 10.3892/ijo.1.1.97.

The anticancer agent N-methylformamide (NMF) suppresses the expression of the c-myc proto-oncogene in human colon carcinoma cells while increasing the doubling time and reducing tumorigenicity in these cells. However, the mechanism by which NMF exerts its effects has remained...

Cite
Delbufalo D, Zupi G, Dagnano I, et al. Growth-inhibition of ht29 cells exposed to N-methylformamide correlates with altered expression of alpha-6/beta-4 integrin. Int J Oncol. 1992;1(1):97-105doi: 10.3892/ijo.1.1.97.
Delbufalo, D., Zupi, G., Dagnano, I., Falcioni, R., Marangolo, M., & Sacchi, A. (1992). Growth-inhibition of ht29 cells exposed to N-methylformamide correlates with altered expression of alpha-6/beta-4 integrin. International journal of oncology, 1(1), 97-105. https://doi.org/10.3892/ijo.1.1.97
Delbufalo, D, et al. "Growth-inhibition of ht29 cells exposed to N-methylformamide correlates with altered expression of alpha-6/beta-4 integrin." International journal of oncology vol. 1,1 (1992): 97-105. doi: https://doi.org/10.3892/ijo.1.1.97
Delbufalo D, Zupi G, Dagnano I, Falcioni R, Marangolo M, Sacchi A. Growth-inhibition of ht29 cells exposed to N-methylformamide correlates with altered expression of alpha-6/beta-4 integrin. Int J Oncol. 1992 Jun;1(1):97-105. doi: 10.3892/ijo.1.1.97. PMID: 21584516.
Copy Download .nbib Format: NLM
[Recent data on chemotherapy of cancer].

Omnia medica. Supplemento

LATARJET R.
PMID: 12983036
Omnia Med Suppl. 1952 Jan-Mar;3(2):151-63.

No abstract available.

Cite
LATARJET R. Recenti dati sulla chemioterapia del cancro. [Recent data on chemotherapy of cancer]. Omnia Med Suppl. 1952;3(2):151-63
LATARJET, R. (1952). Recenti dati sulla chemioterapia del cancro. [Recent data on chemotherapy of cancer]. Omnia medica. Supplemento, 3(2), 151-63.
LATARJET, R. "Recenti dati sulla chemioterapia del cancro." [Recent data on chemotherapy of cancer]. Omnia medica. Supplemento vol. 3,2 (1952): 151-63.
LATARJET R. Recenti dati sulla chemioterapia del cancro. [Recent data on chemotherapy of cancer]. Omnia Med Suppl. 1952 Jan-Mar;3(2):151-63. Undetermined. PMID: 12983036.
Copy Download .nbib Format: NLM
Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens.

International journal of antimicrobial agents

Ferrara A, Dos Santos C, Cimbro M, Grassi GG.
PMID: 18611754
Int J Antimicrob Agents. 1996 Aug;7(3):181-6. doi: 10.1016/s0924-8579(96)00320-2.

Recent macrolide derivatives, roxithromycin, azithromycin and clarithromycin show more favourable pharmacokinetic characteristics in comparison to old ones and some differences in antibacterial activity. With the aim of improving our understanding of some aspects of their action against respiratory pathogens,...

Cite
Ferrara A, Dos Santos C, Cimbro M, et al. Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens. Int J Antimicrob Agents. 1996;7(3):181-6doi: 10.1016/s0924-8579(96)00320-2.
Ferrara, A., Dos Santos, C., Cimbro, M., & Grassi, G. G. (1996). Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens. International journal of antimicrobial agents, 7(3), 181-6. https://doi.org/10.1016/s0924-8579(96)00320-2
Ferrara, A, et al. "Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens." International journal of antimicrobial agents vol. 7,3 (1996): 181-6. doi: https://doi.org/10.1016/s0924-8579(96)00320-2
Ferrara A, Dos Santos C, Cimbro M, Grassi GG. Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens. Int J Antimicrob Agents. 1996 Aug;7(3):181-6. doi: 10.1016/s0924-8579(96)00320-2. PMID: 18611754.
Copy Download .nbib Format: NLM
[Clinical experience of chemotherapy in cancer in advanced phase].

Giornale italiano di chemioterapia

GARDINI GF.
PMID: 13462190
G Ital Chemioter. 1956 Jul-Dec;3(3):408-16.

No abstract available.

Cite
GARDINI GF. Esperienza clinica di chemioterapia nei cancerosi in fase avanzata. [Clinical experience of chemotherapy in cancer in advanced phase]. G Ital Chemioter. 1956;3(3):408-16
GARDINI, G. F. (1956). Esperienza clinica di chemioterapia nei cancerosi in fase avanzata. [Clinical experience of chemotherapy in cancer in advanced phase]. Giornale italiano di chemioterapia, 3(3), 408-16.
GARDINI, G F. "Esperienza clinica di chemioterapia nei cancerosi in fase avanzata." [Clinical experience of chemotherapy in cancer in advanced phase]. Giornale italiano di chemioterapia vol. 3,3 (1956): 408-16.
GARDINI GF. Esperienza clinica di chemioterapia nei cancerosi in fase avanzata. [Clinical experience of chemotherapy in cancer in advanced phase]. G Ital Chemioter. 1956 Jul-Dec;3(3):408-16. Italian. PMID: 13462190.
Copy Download .nbib Format: NLM
[Cardiologic evaluation of patients undergoing chemotherapy].

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Bordoni B, Urbinati S, Tosoni A, Labanti G, Brandes A.
PMID: 25845089
Monaldi Arch Chest Dis. 2014 Jun;82(2):68-74. doi: 10.4081/monaldi.2014.46.

Life expectancy in patients affected by cancer has recently increased because of early diagnosis and actual therapies. In recent years, Oncology and Cardiology developed a tight relationship because of common risk factors (i.e., obesity, smoking, alcool intake, etc...), and...

Cite
Bordoni B, Urbinati S, Tosoni A, et al. La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi Arch Chest Dis. 2014;82(2):68-74doi: 10.4081/monaldi.2014.46.
Bordoni, B., Urbinati, S., Tosoni, A., Labanti, G., & Brandes, A. (2014). La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 82(2), 68-74. https://doi.org/10.4081/monaldi.2014.46
Bordoni, Barbara, et al. "La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate." [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace vol. 82,2 (2014): 68-74. doi: https://doi.org/10.4081/monaldi.2014.46
Bordoni B, Urbinati S, Tosoni A, Labanti G, Brandes A. La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi Arch Chest Dis. 2014 Jun;82(2):68-74. doi: 10.4081/monaldi.2014.46. Italian. PMID: 25845089.
Copy Download .nbib Format: NLM
[What antihumoral chemotherapy offers today and promises for tomorrow].

Minerva medica

TRABUCCHI E.
PMID: 13399899
Minerva Med. 1956 Dec 12;47(99):1969-76.

No abstract available.

Cite
TRABUCCHI E. Quello che la chemioterapia antitumorale offre oggi e promette per il domani. [What antihumoral chemotherapy offers today and promises for tomorrow]. Minerva Med. 1956;47(99):1969-76
TRABUCCHI, E. (1956). Quello che la chemioterapia antitumorale offre oggi e promette per il domani. [What antihumoral chemotherapy offers today and promises for tomorrow]. Minerva medica, 47(99), 1969-76.
TRABUCCHI, E. "Quello che la chemioterapia antitumorale offre oggi e promette per il domani." [What antihumoral chemotherapy offers today and promises for tomorrow]. Minerva medica vol. 47,99 (1956): 1969-76.
TRABUCCHI E. Quello che la chemioterapia antitumorale offre oggi e promette per il domani. [What antihumoral chemotherapy offers today and promises for tomorrow]. Minerva Med. 1956 Dec 12;47(99):1969-76. Italian. PMID: 13399899.
Copy Download .nbib Format: NLM
[Chemotherapy of tuberculosis in cases of ineffectiveness of principle antituberculostatic drugs].

Polski tygodnik lekarski

ZIERSKI M.
PMID: 13633547
Pol Tyg Lek (Wars). 1958 Nov 24;13(47):1862-5.

No abstract available.

Cite
ZIERSKI M. Chemioterapia gruźlicy przy wyczerpaniu i nieskuteczności zasadniczych leków przeciwpratkowych. [Chemotherapy of tuberculosis in cases of ineffectiveness of principle antituberculostatic drugs]. Pol Tyg Lek (Wars). 1958;13(47):1862-5
ZIERSKI, M. (1958). Chemioterapia gruźlicy przy wyczerpaniu i nieskuteczności zasadniczych leków przeciwpratkowych. [Chemotherapy of tuberculosis in cases of ineffectiveness of principle antituberculostatic drugs]. Polski tygodnik lekarski, 13(47), 1862-5.
ZIERSKI, M. "Chemioterapia gruźlicy przy wyczerpaniu i nieskuteczności zasadniczych leków przeciwpratkowych." [Chemotherapy of tuberculosis in cases of ineffectiveness of principle antituberculostatic drugs]. Polski tygodnik lekarski vol. 13,47 (1958): 1862-5.
ZIERSKI M. Chemioterapia gruźlicy przy wyczerpaniu i nieskuteczności zasadniczych leków przeciwpratkowych. [Chemotherapy of tuberculosis in cases of ineffectiveness of principle antituberculostatic drugs]. Pol Tyg Lek (Wars). 1958 Nov 24;13(47):1862-5. Polish. PMID: 13633547.
Copy Download .nbib Format: NLM
On the chemotherapy of tuberculosis with a new Domagk preparation, Tb 1/698.

Minerva medica

ORMEA F.
PMID: 18115411
Minerva Med. 1949 Jan 27;40(5):140.

No abstract available.

Cite
ORMEA F. Sulla chemioterapia della tubercolosi con un nuovo preparato di Domagk, il Tb 1/698. On the chemotherapy of tuberculosis with a new Domagk preparation, Tb 1/698. Minerva Med. 1949;40(5):140
ORMEA, F. (1949). Sulla chemioterapia della tubercolosi con un nuovo preparato di Domagk, il Tb 1/698. On the chemotherapy of tuberculosis with a new Domagk preparation, Tb 1/698. Minerva medica, 40(5), 140.
ORMEA, F. "Sulla chemioterapia della tubercolosi con un nuovo preparato di Domagk, il Tb 1/698." On the chemotherapy of tuberculosis with a new Domagk preparation, Tb 1/698. Minerva medica vol. 40,5 (1949): 140.
ORMEA F. Sulla chemioterapia della tubercolosi con un nuovo preparato di Domagk, il Tb 1/698. On the chemotherapy of tuberculosis with a new Domagk preparation, Tb 1/698. Minerva Med. 1949 Jan 27;40(5):140. Italian. PMID: 18115411.
Copy Download .nbib Format: NLM
[Chemotherapy of malaria].

Il Policlinico. Sezione pratica

PATTERSON AJ.
PMID: 15417359
Policlinico Prat. 1950 Mar 20;57(12):377-85.

No abstract available.

Cite
PATTERSON AJ. Chemioterapia della malaria. [Chemotherapy of malaria]. Policlinico Prat. 1950;57(12):377-85
PATTERSON, A. J. (1950). Chemioterapia della malaria. [Chemotherapy of malaria]. Il Policlinico. Sezione pratica, 57(12), 377-85.
PATTERSON, A J. "Chemioterapia della malaria." [Chemotherapy of malaria]. Il Policlinico. Sezione pratica vol. 57,12 (1950): 377-85.
PATTERSON AJ. Chemioterapia della malaria. [Chemotherapy of malaria]. Policlinico Prat. 1950 Mar 20;57(12):377-85. Undetermined. PMID: 15417359.
Copy Download .nbib Format: NLM
[Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy].

Rivista di ostetricia e ginecologia

Periti P, Gerli P, Cattaneo A.
PMID: 5401184
Riv Ostet Ginecol. 1969 Oct;24(10):293-310.

No abstract available.

Cite
Periti P, Gerli P, Cattaneo A. Aspetti tossicologici della chemioterapia antiblastica con vincaleucoblastina: trattamento intermittente rapido per via endovenosa. [Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy]. Riv Ostet Ginecol. 1969;24(10):293-310
Periti, P., Gerli, P., & Cattaneo, A. (1969). Aspetti tossicologici della chemioterapia antiblastica con vincaleucoblastina: trattamento intermittente rapido per via endovenosa. [Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy]. Rivista di ostetricia e ginecologia, 24(10), 293-310.
Periti, P, et al. "Aspetti tossicologici della chemioterapia antiblastica con vincaleucoblastina: trattamento intermittente rapido per via endovenosa." [Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy]. Rivista di ostetricia e ginecologia vol. 24,10 (1969): 293-310.
Periti P, Gerli P, Cattaneo A. Aspetti tossicologici della chemioterapia antiblastica con vincaleucoblastina: trattamento intermittente rapido per via endovenosa. [Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy]. Riv Ostet Ginecol. 1969 Oct;24(10):293-310. Italian. PMID: 5401184.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 30 entries